This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
reputable news agency
proofread
Few patients with positive margins after basal cell excision have recurrence
![Few patients with positive margins after basal cell excision have recurrence](https://scx1.b-cdn.net/csz/news/800a/2024/few-patients-with-posi-1.jpg)
Among patients with incompletely excised basal cell carcinoma (BCC), only about 16% with positive histopathologic margins have clinical recurrence, according to a study published online June 13 in Dermatology.
Maria Daviti, M.D., from Aristotle University in Thessaloniki, Greece, and colleagues reported the real-life management of incompletely excised BCC in a tertiary referral center and compared recurrence rates according to management modality in a retrospective study.
All BCCs with available histopathologic assay reporting at least one involved margin (lateral or deep) over a five-year period were identified. Patients were categorized into three groups: immediate re-excision (group 1; 26 patients); follow-up without any additional treatment (group 2; 40 patients); and treatment with adjuvant/complementary nonsurgical treatment (group 3; 18 patients).
The researchers found that based on histopathological reports, 53.8% of 26 tumors in group 1 that were re-excised had residual tumor. After a mean follow-up of 17 months, a clinical recurrence occurred in 14 of 84 patients (16.7%), with a median of 14 months to recurrence. Recurrence developed in 25% of the patients without any additional treatment, compared with 11.1% of those receiving nonsurgical treatments.
"Our study suggests that positive histopathologic margins after BCC excision result in a clinical recurrence only in a proportion of patients," the authors write. "This percentage is higher when no further treatment is applied and lower when the area is re-excised or treated with imiquimod alone or combined with cryotherapy."
More information: Maria Daviti et al, Real-Life Data on the Management of Incompletely Excised Basal Cell Carcinoma, Dermatology (2023). DOI: 10.1159/000529367
© 2024 HealthDay. All rights reserved.